These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29473339)

  • 21. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
    Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
    BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
    Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
    Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
    Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
    BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine.
    Park J; Lavelle JP; Palmer MH
    Neurourol Urodyn; 2016 Jan; 35(1):95-9. PubMed ID: 25400112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.
    Lee KS; Yoo TK; Liao L; Wang J; Chuang YC; Liu SP; Chu R; Sumarsono B
    BMC Urol; 2017 Nov; 17(1):108. PubMed ID: 29162085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and safety of tolterodine 2 mg and 4 mg combined with an α-blocker in men with lower urinary tract symptoms (LUTS) and overactive bladder: a randomized controlled trial.
    Kim TH; Jung W; Suh YS; Yook S; Sung HH; Lee KS
    BJU Int; 2016 Feb; 117(2):307-15. PubMed ID: 26305143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
    Cho HJ; Shin SC; Seo DY; Cho JM; Kang JY; Yoo TK; Yu JH; Sung LH; Moon HS
    Int J Clin Pract; 2014 Apr; 68(4):471-7. PubMed ID: 24471868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network.
    Reynolds WS; Suskind AM; Anger JT; Brucker BM; Cameron AP; Chung DE; Daignault-Newton S; Lane GI; Lucioni A; Mourtzinos AP; Padmanabhan P; Reyblat PX; Smith AL; Tenggardjaja CF; Lee UJ;
    Neurourol Urodyn; 2022 Feb; 41(2):662-671. PubMed ID: 35019167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between lower urinary tract symptoms and cardiovascular risk scores in ostensibly healthy women.
    Lee HY; Moon JE; Sun HY; Doo SW; Yang WJ; Song YS; Lee SR; Park BW; Kim JH
    BJU Int; 2019 Apr; 123(4):669-675. PubMed ID: 30281886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
    Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
    Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower urinary tract dysfunction in patients with multiple sclerosis: A post-void residual analysis of 501 cases.
    Monti Bragadin M; Motta R; Messmer Uccelli M; Tacchino A; Ponzio M; Podda J; Konrad G; Rinaldi S; Della Cava M; Battaglia MA; Brichetto G
    Mult Scler Relat Disord; 2020 Oct; 45():102378. PubMed ID: 32683303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Distribution of Post-Void Residual Volumes in People Seeking Care in the Symptoms of Lower Urinary Tract Dysfunction Network Observational Cohort Study With Comparison to Asymptomatic Populations.
    Peterson AC; Smith AR; Fraser MO; Yang CC; DeLancey JOL; Gillespie BW; Gore JL; Talaty P; Andreev VP; Kreder KJ; Mueller MG; Lai HH; Erickson BA; Kirkali Z;
    Urology; 2019 Aug; 130():22-28. PubMed ID: 31018115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis.
    Li T; Xu XX; Dai Y; Zhang JJ; Lang JH; Leng JH
    Chin Med J (Engl); 2017 Jul; 130(13):1552-1556. PubMed ID: 28639570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative Exploration of the Patient Experience of Underactive Bladder.
    Uren AD; Cotterill N; Harding C; Hillary C; Chapple C; Klaver M; Bongaerts D; Hakimi Z; Abrams P
    Eur Urol; 2017 Sep; 72(3):402-407. PubMed ID: 28400168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition and symptoms of underactive bladder.
    Uren AD; Drake MJ
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S61-S67. PubMed ID: 29279877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men.
    Rademakers KL; van Koeveringe GA; Oelke M;
    World J Urol; 2017 Jan; 35(1):153-159. PubMed ID: 27447991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools.
    Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA
    Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.
    Li V; Panicker JN; Haslam C; Chataway J
    J Neurol; 2020 Dec; 267(12):3683-3688. PubMed ID: 32671529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.